| Literature DB >> 24065989 |
Zhang Qiao1, Shi Li-Xing, Peng Nian-Chun, Xu Shu-Jing, Zhang Miao, Li Hong, Zhuang Hui-Jun, Gong Ming-Xian, Zhang Song, Wang Rui, Hu Ying, Zhang Jing-Lu, Chen Shuang.
Abstract
Objective. To evaluate vitamin D status and serum parathyroid hormone (IPTH) of healthy adults living in Guiyang. Design and Participants. We conducted a cross-sectional evaluation in the General Community in Guiyang by cluster sampling method. The data was a part of 1510 participants (634 men, 876 women) aged 20-79 years median 45.2 years from November 2009 to February 2010 in Guiyang Health Measures Survey. Measurements. Aradioimmunoassay was used to measure the level of 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH). Results.The mean serum 25(OH)D level was (20.4 ± 9.0) ng/mL and the highest level among participants aged 40-59 years (22.8 ng/mL). The mean serum PTH level was (32.1 ± 13.7) pg/mL and the lowest level among participants aged 40-50 years (30.8 ng/mL). Serum 25(OH)D was below 50 nmol/liter in 52.3%, below 75 nmol/liter in 84.6%, and above 75 nmol/liter in 15.4% of the respondents. Secondary hyperparathyroidism was 5.4% (5.4% among men and 4.6% among women). The prevalence of secondary hyperparathyroidism increased (5.8%, 6.5%, and 7.1%, resp.) with decreasing serum 25(OH)D levels among subjects who were 30 to 20, 19.9 to 10, and <10 ng/mL, respectively. Serum 25(OH)D was inversely associated with serum PTH. Conclusions. Vitamin D insufficiency and its complication of secondary hyperparathyroidism are common.Entities:
Year: 2013 PMID: 24065989 PMCID: PMC3771443 DOI: 10.1155/2013/150461
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Baseline characteristics (n = 1510).
| Parameter | Total sample | Men | Women |
|---|---|---|---|
| Age (yr) | |||
| 20– | 267 (17.7) | 115 (18.1) | 152 (17.4) |
| 30– | 351 (23.2) | 148 (23.3) | 203 (23.2) |
| 40– | 329 (21.8) | 135 (21.3) | 194 (22.1) |
| 50– | 284 (18.8) | 118 (18.6) | 166 (18.9) |
| 60– | 155 (10.3) | 60 (9.5) | 95 (10.8) |
| 70– | 124 (8.2) | 58 (9.1) | 66 (7.5) |
| 20–79 | 1510 (100) | 634 (42.0) | 876 (58.0) |
| Alcohol (%) | 444 (29.4) | 376 (59.3) | 68 (7.8)a |
| Smoker (%) | 250 (16.6) | 206 (32.5) | 44 (5.0)a |
| Drinking milk | 297 (19.7) | 118 (18.6) | 179 (20.4) |
| Calcium supplementation | 179 (11.9) | 51 (8.0) | 128 (14.6) |
| Vitamin D supplementation | 48 (3.2) | 15 (2.4) | 33 (3.8) |
| Outdoors activity | |||
| ≤30 min/day | 842 (55.8) | 377 (59.5) | 465 (53.1) |
| 30–60 min/day | 351 (23.2) | 146 (23.0) | 205 (23.4) |
| ≥60 min/day | 314 (20.8) | 109 (17.2) | 205 (23.4) |
| Education (yr) | |||
| 0–6 | 205 (13.6) | 51 (8.0) | 154 (17.6) |
| 7–9 | 408 (27.0) | 144 (22.7) | 264 (30.1) |
| 10–12 | 353 (23.4) | 142 (22.4) | 211 (24.1) |
| ≥13 | 544 (36.0) | 297 (46.8) | 247 (28.2) |
| BMI (Kg/m2) | 23.7 ± 3.6 | 24.1 ± 3.3 | 23.4 ± 3.7a |
| Waist circumference (cm) | 81.6 ± 9.8 | 85.4 ± 8.9 | 78.7 ± 9.4a |
| Waist/hip ratio | 0.86 ± 0.06 | 0.89 ± 0.06 | 0.83 ± 0.06a |
| Total calcium (mmol/L) | 2.4 ± 0.2 | 2.4 ± 0.2 | 2.4 ± 0.2 |
| Phosphate (mmol/L) | 1.1 ± 0.2 | 1.0 ± 0.2 | 1.1 ± 0.1a |
| Creatinine (umol/L) | 63.7 ± 14.7 | 74.6 ± 12.7 | 55.8 ± 10.2a |
| 25(OH)D (ng/mL) | 20.4 ± 9.0 | 20.8 ± 9.7 | 20.1 ± 8.5 |
| iPTH (pg/mL) | 32.1 ± 13.7 | 33.5 ± 12.4 | 30.5 ± 13.6a |
Values are presented as mean ± SD. For conversion of 25(OH)D from nmol/liter to ng/mL, divide by 2.496; for conversion of PTH from pmol/liter to pg/mL, multiply by 11.1. Distribution of PTH and of a number of chronic diseases was skewed. Median (interquartile range) is presented; serum 25(OH)D was assessed in a sample (n = 1494) and iPTH (n = 1414). a P < 0.01 as compared to men.
Differences in the mean values of BMI, Serum 25(OH)D, PTH, calcium, Phosphorus, and Creatinine in different age groups (n = 1510).
| Parameter | Youth ( | Middle age ( | Senior ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total sample | Men | Women | Total sample | Men | Women | Total sample | Men | Women | |
| Age (yr) | 30.8 ± 5.7 | 30.4 ± 5.5 | 31.1 ± 5.8 | 49.2 ± 5.5 | 49.2 ± 5.8 | 49.2 ± 5.8 | 68.1 ± 4.5 | 68.9 ± 4.2 | 67.5 ± 4.6 |
| BMI (kg/m2) | 22.5 ± 3.6 | 23.5 ± 3.6 | 21.7 ± 3.4 | 24.3 ± 3.3 | 24.5 ± 3.1 | 24.2 ± 3.4 | 25.0 ± 3.4 | 24.6 ± 2.9 | 25.4 ± 3.6 |
| 25(OH)D (ng/mL) | 18.2 ± 9.2a | 17.6 ± 9.5a | 18.7 ± 9.0 | 22.8 ± 8.7 | 23.4 ± 8.5 | 22.4 ± 8.1 | 19.9 ± 7.8a | 22.2 ± 8.4 | 18.2 ± 6.9b |
| iPTH (pg/mL) | 33.0 ± 13.2a | 32.3 ± 12.3 | 33.5 ± 13.8 | 30.8 ± 13.3 | 35.0 ± 13.9 | 27.9 ± 12.1b | 32.8 ± 15.2a | 35.6 ± 14.1 | 30.8 ± 15.7b |
| Total calcium (mmol/mL) | 2.4 ± 0.1 | 2.4 ± 0.1 | 2.4 ± 0.1 | 2.4 ± 0.2 | 2.4 ± 0.1 | 2.4 ± 0.2 | 2.4 ± 0.2 | 2.4 ± 0.2 | 2.4 ± 0.2 |
| Phosphate (mmol/mL) | 1.1 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.1 | 1.1 ± 0.2 | 1.0 ± 0.2 | 1.1 ± 0.1b | 1.0 ± 0.2 | 1.0 ± 0.1 | 1.1 ± 0.1b |
| Creatinine (umol/L) | 67.1 ± 14.1 | 69.3 ± 11.5 | 66.5 ± 14.7 | 73.8 ± 10.4 | 74.2 ± 12.3 | 71.9 ± 11.1 | 76.6 ± 13.1c | 78.4 ± 11.5 | 74.7 ± 10.6 |
Values are presented as mean ± SD. For conversion of 25(OH)D from nmol/liter to ng/mL, divide by 2.496; for conversion of PTH from pmol/liter to pg/mL, multiply by 11.1. Distribution of PTH was skewed. Median (interquartile range) are presented; serum 25(OH)D was assessed in a sample (n = 1494) and iPTH (n = 1414). a P < 0.01, as compared to the middle age category, b P < 0.01, as compared to men, c P < 0.01, as compared to youth category.
25(OH)D concentrations by participant characteristics (n = 1510).
| Parameter | 25(OH)D concentrations | |||
|---|---|---|---|---|
| Male | Female | |||
| BMI (Kg/m2) | 0.021 | 0.004 | ||
| <18.5 | 17.6 ± 10.8 | 16.7 ± 10.0 | ||
| 18.5–23.9 | 19.9 ± 10.2 | 20.7 ± 8.7 | ||
| 24–27.9 | 22.1 ± 9.2 | 20.1 ± 7.8 | ||
| ≥28 | 20.1 ± 8.6 | 19.5 ± 7.6 | ||
| Waist circumference | 0.45 | 0.78 | ||
| Normal | 20.3 ± 10.2 | 20.2 ± 8.9 | ||
| Abnormal | 21.2 ± 9.2 | 20.1 ± 7.9 | ||
| WHR | 0.075 | 0.043 | ||
| Normal | 20.0 ± 10.7 | 21.0 ± 9.0 | ||
| Abnormal | 20.9 ± 9.4 | 19.7 ± 8.3 | ||
| Education (yr) | <0.001 | <0.001 | ||
| 0–6 | 25.6 ± 7.6 | 20.1 ± 7.6 | ||
| 7–9 | 22.7 ± 10.2 | 21.0 ± 7.8 | ||
| 10–12 | 20.7 ± 9.0 | 22.0 ± 8.6 | ||
| ≥13 | 19.0 ± 9.6 | 17.6 ± 9.0 | ||
| Outdoors activity | 0.007 | 0.005 | ||
| <30 min/day | 20.2 ± 9.7 | 19.9 ± 8.7 | ||
| 30–60 min/day | 19.9 ± 9.3 | 19.1 ± 7.4 | ||
| ≥60 min/day | 23.4 ± 9.0 | 21.7 ± 8.7 | ||
| Smoking | 0.006 | 0.009 | ||
| Yes | 18.3 ± 9.6 | 17.8 ± 8.9 | ||
| No | 21.4 ± 9.7 | 20.0 ± 8.4 | ||
| Drinking alcohol | 0.064 | 0.078 | ||
| Yes | 21.3 ± 9.4 | 20.8 ± 8.9 | ||
| No | 22.4 ± 9.4 | 20.4 ± 8.4 | ||
| Drinking milk | 0.017 | 0.042 | ||
| Yes | 22.8 ± 10.1 | 21.2 ± 8.2 | ||
| No | 20.3 ± 9.5 | 18.6 ± 8.5 | ||
| Calcium supplementation | 0.060 | 0.009 | ||
| Yes | 23.1 ± 9.8 | 21.9 ± 8.5 | ||
| No | 20.5 ± 9.7 | 19.8 ± 8.4 | ||
| Vitamin D supplementation | 0.059 | 0.054 | ||
| Yes | 23.2 ± 9.5 | 21.9 ± 7.2 | ||
| No | 20.7 ± 9.7 | 20.0 ± 8.5 | ||
Data are expressed as means ± SD, the comparison between each group was tested by ANOVA or chi-square.
Multiple factor logistic regression of low serum 25(OH)D of less than 30 ng/mL.
| Variables |
| OR (95% CI) |
|
|---|---|---|---|
| Age | |||
| 20–39 yr | 0.613 (0.167) | 1.846 (1.332–2.559) | <0.001 |
| 40–59 yr | — | — | |
| 60–79 yr | 0.651 (0.216) | 1.918 (1.256–2.929) | 0.003 |
| Waist/hip ratio | |||
| Normal | |||
| Abnormal | 0.444 (0.161) | 1.559 (1.137–2.138) | 0.006 |
| Outdoors activity | |||
| <30 min/day | 0.290 (0.179) | 1.337 (0.941–1.898) | 0.105 |
| 30–60 min/day | 0.401 (0.172) | 1.490 (0.970–2.228) | 0.050 |
| ≥60 min/day | — | — | |
| Smoking | |||
| Yes | 0.435 (0.211) | 1.506 (0.097–2.337) | 0.049 |
| No | — | — |
Multiple factor logistic regression of high serum PTH of greater than normal levels.
| Variables |
|
|
|---|---|---|
| Sex | −0.114 | <0.001 |
| 25(OH)D | −0.101 | <0.001 |
| Total calcium (mmol/mL) | −0.101 | 0.002 |
| Creatinine (umol/L) | 0.061 | 0.022 |
| Height | 0.108 | <0.001 |
| Weight | 0.072 | 0.007 |
| Waist/hip ratio | 0.079 | 0.003 |
| Waist circumference (cm) | 0.082 | 0.01 |